FDA
approval
· 2021-09-27
FDA Approved: HYCODAN — Supplemental Application (Genus Lifesciences Inc.)
Summary
The FDA granted a supplemental approval for HYCODAN, a hydrocodone bitartrate and homatropine methylbromide combination product from Genus Lifesciences Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for HYCODAN (HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE)